A Biochemical/Biophysical Assay Dyad for HTS-Compatible Triaging of Inhibitors of the HIV-1 Nef/Hck SH3 Interaction
Name:
Article-Current_Ch-A_Biochemi-2013-07-26.pdf
Size:
446.3Kb
Format:
PDF
Description:
Article - Full Text
Type
ArticleAuthors
Breuer, SebastianEspinola, Sheryll
Morelli, Xavier
Torbett, Bruce E
Arold, Stefan T.

Engels, Ingo H
KAUST Department
Biological and Environmental Sciences and Engineering (BESE) DivisionBioscience Program
Computational Bioscience Research Center (CBRC)
Structural Biology and Engineering
Date
2013-07-26Permanent link to this record
http://hdl.handle.net/10754/334597
Metadata
Show full item recordAbstract
The current treatment regimens for HIV include over 20 anti-retrovirals. However, adverse drug effects and the emergence of drug resistance necessitates the continued improvement of the existing drug classes as well as the development of novel drugs that target as yet therapeutically unexploited viral and cellular pathways. Here we demonstrate a strategy for the discovery of protein-protein interaction inhibitors of the viral pathogenicity factor HIV-1 Nef and its interaction with the host factor SH3. A combination of a time-resolved fluorescence resonance energy resonance energy transfer-based assay and a label-free resonant waveguide grating-based assay was optimized for high-throughput screening formats.Citation
Breuer S (2013) A Biochemical/Biophysical Assay Dyad for HTS-Compatible Triaging of Inhibitors of the HIV-1 Nef/Hck SH3 Interaction. Current Chemical Genomics and Translational Medicine 7: 16-20. doi:10.2174/2213988501307010016.Publisher
Bentham Science Publishers Ltd.PubMed ID
24396731PubMed Central ID
PMC3854662ae974a485f413a2113503eed53cd6c53
10.2174/2213988501307010016
Scopus Count
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Related articles
- A mammalian two-hybrid screening system for inhibitors of interaction between HIV Nef and the cellular tyrosine kinase Hck.
- Authors: Murakami Y, Fukazawa H, Kobatake T, Yamagoe S, Takebe Y, Tobiume M, Matsuda M, Uehara Y
- Issue date: 2002 Jul
- HIV-1 Nef interaction influences the ATP-binding site of the Src-family kinase, Hck.
- Authors: Pene-Dumitrescu T, Shu ST, Wales TE, Alvarado JJ, Shi H, Narute P, Moroco JA, Yeh JI, Engen JR, Smithgall TE
- Issue date: 2012 Mar 15
- HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction.
- Authors: Trible RP, Emert-Sedlak L, Smithgall TE
- Issue date: 2006 Sep 15
- Conserved residues in the HIV-1 Nef hydrophobic pocket are essential for recruitment and activation of the Hck tyrosine kinase.
- Authors: Choi HJ, Smithgall TE
- Issue date: 2004 Nov 5
- Structure, function, and inhibitor targeting of HIV-1 Nef-effector kinase complexes.
- Authors: Staudt RP, Alvarado JJ, Emert-Sedlak LA, Shi H, Shu ST, Wales TE, Engen JR, Smithgall TE
- Issue date: 2020 Oct 30